10.02
전일 마감가:
$9.69
열려 있는:
$10.15
하루 거래량:
26,020
Relative Volume:
1.30
시가총액:
$870.50M
수익:
$213.45M
순이익/손실:
$-72.46M
주가수익비율:
-10.08
EPS:
-0.9936
순현금흐름:
$-47.28M
1주 성능:
+7.40%
1개월 성능:
+2.66%
6개월 성능:
+6.60%
1년 성능:
+20.29%
발네바 Stock (VALN) Company Profile
Compare VALN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
VALN
Valneva Se Adr
|
10.02 | 841.83M | 213.45M | -72.46M | -47.28M | -0.9936 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
발네바 Stock (VALN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 재개 | H.C. Wainwright | Buy |
| 2022-08-03 | 개시 | H.C. Wainwright | Buy |
발네바 주식(VALN)의 최신 뉴스
Valneva (NASDAQ:VALN) Sees Large Volume IncreaseHere's Why - MarketBeat
VALNEVA Declaration of shares and voting rights: January 31, 2026 - GlobeNewswire Inc.
Valneva (NASDAQ:VALN) Shares Gap UpTime to Buy? - MarketBeat
Valneva (NASDAQ:VALN) Stock Price Down 5.6%Here's What Happened - MarketBeat
Valneva (NASDAQ:VALN) Shares Gap DownTime to Sell? - MarketBeat
Valneva stock falls after withdrawing chikungunya vaccine BLA in U.S. By Investing.com - Investing.com Nigeria
Valneva stock falls after withdrawing chikungunya vaccine BLA in U.S. - Investing.com
Valneva (NASDAQ:VALN) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
VLA Stock Price and Chart — EURONEXT:VLA - TradingView — Track All Markets
Valneva (NASDAQ:VALN) Shares Up 4.9%What's Next? - MarketBeat
Valneva (NASDAQ:VALN) Stock Price Down 4.6%Time to Sell? - MarketBeat
Valneva (NASDAQ:VALN) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Frazier Life Sciences Management L.P. Makes New Investment in Valneva SE Sponsored ADR $VALN - MarketBeat
Valneva stock rises after positive final Phase 2 results for chikungunya vaccine - Investing.com India
Valneva (NASDAQ:VALN) Stock Price Down 3.1%What's Next? - MarketBeat
Valneva stock rises after positive Lyme disease vaccine booster data - Investing.com
Valneva SE earnings beat by $0.02, revenue fell short of estimates - Investing.com
Valneva (VALN) Projected to Post Earnings on Thursday - MarketBeat
Disney, Brookfield, Nu Holdings and more set to report earnings Thursday - Investing.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SEVALN - 2822news.com
Free cash flow per share of Valneva SE Sponsored ADR – LS:A3CPD1 - TradingView
Valneva SE Sponsored ADR (NASDAQ:VALN) Short Interest Update - MarketBeat
Valneva's (VALN) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Valneva (NASDAQ:VALN) Trading Down 0.8%Time to Sell? - MarketBeat
Valneva (NASDAQ:VALN) Trading Down 0.8% – Time to Sell? - Defense World
Valneva (NASDAQ:VALN) Stock Price Down 4.9%Here's Why - MarketBeat
Kepler Capital Sticks to Its Buy Rating for Valneva (0OB3) - Barchart.com
Valneva–Aktie: Finanzierung gesichert, Erwartungen gesenkt! - Finanztrends
Valneva stock falls after FDA suspension forces guidance cut - Investing.com
Valneva’s Ixchiq shows 95% 4-year antibody persistence, shares up 10% - Investing.com
발네바 (VALN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):